Prognostic utility of single-photon emission computed tomography in adult patients with hypertrophic cardiomyopathy

American Heart Journal

Volumn 151, Issue 2, 2006, Pages 426-435

  Sorajja, Paul ^a   Chareonthaitawee, Panithaya ^a   Ommen, Steve R ^a   Miller, Todd D ^a   Hodge, David O ^a   Gibbons, Raymond J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOISOTOPE; THALLIUM 201;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHARMACOLOGIC STRESS TESTING; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY ARTERIOSCLEROSIS; FEMALE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PROGNOSIS; RADIOPHARMACEUTICALS; SURVIVAL RATE; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 31344454392     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.02.050     Document Type: Article

References (40)

1. B. Schwartzkopff, M. Mundhenke, and B.E. Strauer Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia J Am Coll Cardiol 31 1998 1089 1096
2. B.J. Maron, J.K. Wolfson, and S.E. Epstein Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy J Am Coll Cardiol 8 1986 545 547
3. J. Radvan, L. Choudhury, and D.J. Sheridan Comparison of coronary vasodilator reserve in elite rowing athletes versus hypertrophic cardiomyopathy Am J Cardiol 80 1997 1621 1623
4. F. Cecchi, I. Olivotto, and R. Gistri Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy N Engl J Med 349 2003 1027 1035
5. P.M. Elliott, J.C. Kaski, and K. Prasad Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study Eur Heart J 17 1996 1056 1064
6. R. Lorenzoni, R. Gistri, and F. Cecchi Syncope and ventricular arrhythmias in hypertrophic cardiomyopathy are not related to the derangement of coronary microvascular function Eur Heart J 18 1997 1946 1950
7. P.M. Elliott, G.M.C. Rosano, and J.S. Gill Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy Heart 75 1996 179 183
8. E. Lazzeroni, E. Picano, and L. Morozzi Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult patients with hypertrophic cardiomyopathy Circulation 96 1997 4268 4272
9. P.T. O'Gara, R.O. Bonow, and B.J. Maron Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography Circulation 76 1987 1214 1223
10. V. Dilsizian, R.O. Bonow, and S.E. Epstein Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy J Am Coll Cardiol 22 1993 796 804
11. T.W. Von Dohlen, L.M. Prisant, and M.J. Frank Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy Am J Cardiol 64 1989 498 503
12. M. Yamada, P.M. Elliott, and K. Prasad Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy: relation to clinical presentation and outcome Eur Heart J 19 1998 500 507
13. P. Hanrath, D. Mathey, and R. Montz Myocardial thallium-201 imaging in hypertrophic obstructive cardiomyopathy Eur Heart J 2 1981 177 185
14. R.O. Cannon, V. Dilsizian, and P.T. O'Gara Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy Circulation 83 1991 1660 1667
15. R.P. Ward, H.K. Pokharna, and R.M. Lang Resting "solar polar" map pattern and reduced apical flow reserve: characteristics of apical hypertrophic cardiomyopathy on SPECT myocardial perfusion imaging J Nucl Cardiol 10 2003 506 512
16. B.J. Maron, I. Olivotto, and P. Spirito Epidemiology of hypertrophic cardiomyopathy-related death. Revisited in a large non-referral-based patient population Circulation 102 2000 858 864
17. I. Olivotto, F. Cecchi, and S. Casey Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy Circulation 104 2001 2517 2524
18. B.J. Maron, I. Olivotto, and P. Bellone Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy J Am Coll Cardiol 39 2002 301 307
19. P. Sorajja, S.R. Ommen, and R.A. Nishimura Adverse prognosis of patients with hypertrophic cardiomyopathy and epicardial coronary artery disease Circulation 108 2003 2342 2348
20. P. Richardson, W. McKenna, and M. Bristow Report of the World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies Circulation 93 1996 841 842
21. B.J. Maron, J.S. Gottdiener, and S.E. Epstein Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle two dimensional echocardiographic study of 125 patients Am J Cardiol 48 1981 418 428
22. L.M. Shapiro, and W.J. McKenna Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study J Am Coll Cardiol 2 1983 437 444
23. R.E. Vlietstra, R.L. Frye, and R.A. Kronmal Risk factors and angiographic coronary artery disease: a report from the coronary artery surgery study (CASS) Circulation 62 1980 254 261
24. R.J. Gibbons, J. Abrams, and K. Chatterjee ACC/AHA 2002 guideline update for the management of patients with chronic stable angina J Am Coll Cardiol 40 2002 1531 1540
25. T.F. Christian, T.D. Miller, and K.R. Bailey Noninvasive identification of severe coronary artery disease using exercise tomographic thallium-201 imaging Am J Cardiol 70 1992 14 20
26. D.L. Johnston, J.R. Daley, and D.O. Hodge Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: a comparison in 2,000 patients Mayo Clin Proc 70 1995 331 336
27. T.D. Miller, D.O. Hodge, and T.F. Christian Effects of adjustment for referral bias on the sensitivity and specificity of single photon emission computed tomography for the diagnosis of coronary artery disease Am J Med 112 2002 290 297
28. D.S. Berman, H. Kiat, and K. Van Train Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols J Nucl Med 35 1994 681 688
29. R. Hachamovitch, D.S. Berman, and H. Kiat Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification Circulation 93 1996 905 914
30. T.D. Miller, H.P. Chaliki, and T.F. Christian Usefulness of worsening clinical status or exercise performance in predicting future events in patients with coronary artery disease Am J Cardiol 88 2001 1294 1297
31. D.S. Berman, R. Hachamovitch, and H. Kiat Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography J Am Coll Cardiol 26 1995 639 647
32. K.A. Brown Prognostic value of thallium-201 myocardial perfusion imaging: a diagnostic tool comes of age Circulation 83 1991 363 381
33. S. Iskander, and A.E. Iskandrian Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging J Am Coll Cardiol 32 1998 57 62
34. R.J. Gibbons, K. Chatterjee, and J. Daley ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on management of patients with chronic stable angina) J Am Coll Cardiol 33 1999 2092 2197
35. J. Takata, P.J. Counihan, and J.N. Gane Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain Am J Cardiol 72 1993 211 217
36. A.M. Varnava, P.M. Elliott, and N. Mahon Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy Am J Cardiol 88 2001 275 279
37. P. Spirito, C.E. Seidman, and W.J. McKenna The management of hypertrophic cardiomyopathy N Engl J Med 336 1997 775 785
38. M.S. Maron, I. Olivotto, and S. Betocchi Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 2003 295 303
39. B.J. Maron, S.A. Casey, and L.C. Poliac Clinical course of hypertrophic cardiomyopathy in a regional United States cohort JAMA 281 1999 650 655
40. P. Camici, G. Chiriatti, and R. Lorenzoni Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography J Am Coll Cardiol 17 1991 879 886